In August 2026 Norstella launched Atlas, an agentic AI layer over Citeline, Evaluate, MMIT and Panalgo. It's a real step forward, but it reasons over Norstella's own proprietary data. One Zyme reasons across that same landscape plus patents, filings, financings, literature and native, real-time China, and returns a cited answer, not just the records.
Citeline is trusted for trial and pipeline curation, and Atlas now puts an agent on top of it. But that agent only sees Norstella's own brands, so connecting to everything else still falls to you.
Atlas grounds its answers in Norstella's own data. One Zyme reasons across that plus patents, filings, financings, literature and conferences, open and proprietary together, so the record becomes a decision, not a data point.
Norstella’s China depth trails its Western coverage, and Atlas inherits that gap. One Zyme reads China’s regulatory, clinical, and corporate sources natively and in real time.
Atlas keeps you inside one vendor's data and ontology. One Zyme is source-neutral, reasoning across every provider's signal and citing each claim back to its origin.
Persona agents (Atlas CI) with fixed deliverables; still generic to your pipeline.
Atlas agents answer in natural language, within Norstella's own data.
Citeline, Evaluate, MMIT & Panalgo connected; open web, patents & literature sit outside.
Western coverage leads; Atlas inherits the China lag.
Atlas synthesizes, over Norstella's curated corpus only.
Curation cadence introduces lag.
Four brands bundled into Atlas; still priced as a suite.
See One Zyme run live on a target of your choice, and compare the answer to what your current stack returns.
